← 返回

单细胞 RNA 测序揭示光动力治疗结直肠癌小鼠模型中肿瘤浸润 T 淋巴细胞的免疫肿瘤学特征

英文原题:Single-Cell RNA Sequencing Reveals Immuno-Oncology Characteristics of Tumor-Infiltrating T Lymphocytes in Photodynamic Therapy-Treated Colorectal Cancer Mouse Model.

查看英文原题

Single-Cell RNA Sequencing Reveals Immuno-Oncology Characteristics of Tumor-Infiltrating T Lymphocytes in Photodynamic Therapy-Treated Colorectal Cancer Mouse Model.

PubMed 2023/09/10(内容时间) Int J Mol Sci Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

光动力疗法(PDT)在减少转移性结直肠癌(CRC)方面已显示出前景;然而,其潜在机制仍不清楚。通过PDT调节肿瘤浸润免疫细胞或许可以实现,这需要通过单细胞RNA测序(scRNA-seq)来表征肿瘤微环境中的免疫细胞群体。

在此,我们利用scRNA-seq分析确定了二氢卟吩e6(Ce6)介导的PDT对肿瘤浸润T细胞的影响。我们使用了人源化程序性死亡-1/程序性死亡配体1(PD-1/PD-L1)MC38细胞同种移植小鼠模型,考虑到其作为免疫原性癌症模型的潜力以及与PD-1/PD-L1免疫检查点阻断的联合应用。PDT治疗显著减少了携带hPD-1/PD-L1 MC38肿瘤小鼠的肿瘤生长。scRNA-seq分析显示,PDT组CD8+活化T细胞和CD8+细胞毒性T细胞水平升高,但耗竭性CD8+T细胞水平降低。PDT治疗还增强了CD8+T细胞向肿瘤的浸润,并增加了关键效应分子的产生,包括颗粒酶B和穿孔素1。这些发现为CRC患者的免疫治疗调节提供了见解,并突出了PDT在克服免疫逃逸和增强抗肿瘤免疫方面的潜力。

展开英文摘要原文

Photodynamic therapy (PDT) has shown promise in reducing metastatic colorectal cancer (CRC); however, the underlying mechanisms remain unclear. Modulating tumor-infiltrating immune cells by PDT may be achieved, which requires the characterization of immune cell populations in the tumor microenvironment by single-cell RNA sequencing (scRNA-seq).

Here, we determined the effect of Chlorin e6 (Ce6)-mediated PDT on tumor-infiltrating T cells using scRNA-seq analysis.

We used a humanized programmed death-1/programmed death ligand 1 (PD-1/PD-L1) MC38 cell allograft mouse model, considering its potential as an immunogenic cancer model and in combination with PD-1/PD-L1 immune checkpoint blockade. PDT treatment significantly reduced tumor growth in mice containing hPD-1/PD-L1 MC38 tumors.

scRNA-seq analysis revealed that the PDT group had increased levels of CD8 + activated T cells and CD8 + cytotoxic T cells, but decreased levels of exhausted CD8 + T cells. PDT treatment also enhanced the infiltration of CD8 + T cells into tumors and increased the production of key effector molecules, including granzyme B and perforin 1.

These findings provide insight into immune-therapeutic modulation for CRC patients and highlight the potential of PDT in overcoming immune evasion and enhancing antitumor immunity.

论文信息

作者
Lee EJ、Choi JG、Han JH、Kim YW、Lim J、Chung HS
单位
Korean Medicine Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea.South Korea
期刊
International journal of molecular sciences2023 Sep 10
原文标识
PubMed 37762216 · DOI 10.3390/ijms241813913